ClinicalTrials.gg
CompletedNCT07765420Updated Aug 14, 2026

A Clinical Trial to Evaluate the Effects of an Electrolyte Supplement on Women's Wellness

An interventional study of Daily Love Electrolytes in Low Energy, Dehydration and Bloating, sponsored by Love Wellness. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Love Wellness · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Apr 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the effects of the Daily Love Electrolytes supplement on women's wellness over a 4-week period. The primary focus is on perceived hydration and energy levels, assessed via self-reported questionnaires at Baseline, Week 1, Week 2, Week 3, and Week 4.

This is a single-arm, open-label, virtual trial enrolling 40 female participants aged 18 and older who have experienced low energy and feelings of dehydration in the past four weeks. All participants will take two electrolyte tablets daily as directed throughout the 4-week study duration.

02

Conditions studied

  • Low Energy
  • Dehydration
  • Bloating
  • Women's Wellness

Browse trials for

03

In context

Dehydration

201 studies on the registry are indexed under Dehydration; 28 are open to participants now.

This study's enrollment of 40 is close to the median of 43 across 145 interventional studies indexed under Dehydration.

Browse Dehydration studies →

Lead sponsor

Love Wellness is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be female
  • Be aged 18+
  • Anyone experiencing issues regarding all of the following over the past four weeks: low energy and feeling dehydrated
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease
  • Willing to refrain from taking any products, prescription medications, or supplements that target energy, hydration, and general wellness during the test period
  • Willing to maintain a consistent level of water intake for the duration of the study
  • Willing to avoid other hydration products, including soluble products or pre-made beverages such as Pedialyte or Gatorlyte
  • Willing to maintain current diet, sleep schedule, and activity level for the duration of the study
  • Resides in the United States
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 4 weeks and at any point during this study's duration

Exclusion criteria

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would impact participation in the study, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Anyone taking prescription Eskalith or Lithobid (lithium)
  • Anyone taking prescription Lanoxin (digoxin)
  • Anyone diagnosed with and is being treated for Parkinson's Disease with prescription medications
  • Anyone taking prescription antibiotics in the study duration
  • Anyone diagnosed with kidney disease
  • Anyone unwilling to follow the study protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Daily Love Electrolytes

    Dietary Supplement: Daily Love Electrolytes

Interventions

  • Dietary supplementDaily Love Electrolytes

    All 40 participants receive the Daily Love Electrolytes supplement. Two tablets are taken per day (one at 11am and one at 3pm), each dissolved in 16 fl.oz/475 mL of water, with or without food, for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change in Perceived Hydration

    Mean change in self-reported hydration assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  2. Change in Perceived Energy

    Mean change in self-reported energy assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

Secondary outcomes

  1. Participant Perception of Hydration

    Self-reported perception of the product's effects on hydration assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  2. Participant Perception of Energy

    Self-reported perception of the product's effects on energy assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  3. Participant Perception of General Feelings of Wellness

    Self-reported perception of general feelings of wellness assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  4. Participant Perception of Getting More Out of Diet and Wellness Routines

    Self-reported perception of getting more out of diet and wellness routines assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  5. Participant Perception of Bloating

    Self-reported perception of the product's effects on bloating assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

  6. Participant Perception of Ease of Use

    Self-reported perception of the product's ease of use assessed via questionnaire

    Time frame: Baseline, Week 1, Week 2, Week 3, and Week 4

07

Study locations

1 site
  • Citruslabs
    Las Vegas, Nevada 89101, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07765420
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Apr 7, 2025
Primary completion
Nov 6, 2025
Completion
Nov 6, 2025
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion